ScreenerHero

ANCRAnimalcare Group plc

Data unavailable
LSE · GB · Healthcare · Drug Manufacturers - Specialty & Generic · animalcaregroup.com
335.00GBP0.00%Mkt Cap: 296.67M $P/E: 47.86

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally. It op…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.19BUSDP/E 23.7
TAK
Takeda Pharmaceutical Co. Ltd.
$58.06BUSD
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.98BUSDP/E 20.4
TEVA
Teva Pharmaceutical Industries Limited
$43.51BUSDP/E 62.2
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
ZTS
Zoetis Inc.
$32.12BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.01BUSDP/E 18.4
VTRS
Viatris, Inc.
$18.75BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.34BUSDP/E 117.3
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
NBIX
Neurocrine Biosciences, Inc.
$15.51BUSDP/E 22.3
ELAN
Elanco Animal Health Incorporat
$11.98BUSD
RDY
Dr. Reddy's Laboratories Ltd
$10.15BUSDP/E 29.7
KRK
Krka, d. d.
$8.66BUSDP/E 19.0
ALKS
Alkermes plc
$8.11BUSDP/E 127.2
HIMS
Hims & Hers Health, Inc.
$7.88BUSD
LNTH
Lantheus Holdings Inc
$6.53BUSDP/E 23.9
AMRX
Amneal Pharmaceuticals, Inc. Class A
$6.24BUSDP/E 37.3
LQDA
Liquidia Corporation
$6.14BUSDP/E 49.0
KNSA
Kiniksa Pharmaceuticals, Ltd.
$6.08BUSDP/E 79.8

Key Statistics

Company
Market Cap296.67M $
Enterprise Value312.44M $
Revenue (TTM)114.29M $
Gross Profit65.90M $
Net Income (TTM)6.51M $
Revenue/Share1.651 USD
Last Price335.00 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees220
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)47.86
P/E (Forward)2133.76
PEG—
EV/EBITDA18.93
EV/Revenue2.73
P/S2.60
P/B201.93
EPS (TTM)0.07
EPS (Forward)0.16
52W Range
0.000099% of range340.00
52W High340.00 GBP
52W Low0.0000 GBP
Profitability
Gross Margin57.66%
Oper. Margin4.83%
EBITDA Margin14.44%
Profit Margin5.70%
ROE4.43%
ROA3.21%
Growth
Revenue Growth21.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF15.15M $
CapEx (TTM)5.45M $
FCF Margin70.47%
FCF Yield27.15%
Net Debt15.77M $
Net Debt/EBITDA0.96
Balance Sheet
Debt/Equity0.13
Current Ratio1.61
Quick Ratio0.95
Book Value/Sh1.659 GBP
Cash/Share0.0420 GBP
Dividends
Fwd Div Rate0.0500 GBP
Trail. Div Rate0.0220 GBP
Div. Yield1.55%
5Y Avg Yield1.91%
Payout Ratio71.23%
Ex-Div DateOct 16, 2025
Pay Date—
Analyst Consensus
Rating—
Target (Mean)336.00 GBP
Upside (mean)+0.3%
Target Range336.00 GBP – 336.00 GBP
# Analysts1
Ownership
Shares Out.69.05M
Float41.14M
Insiders27.39%
Institutions61.87%
Technical
SMA 50332.58 (+0.7%)
SMA 200284.06 (+17.9%)
Beta0.67
S&P 52W Chg20.73%
Avg Vol (30d)225.91K
Avg Vol (10d)360.02K
Technical Indicators
RSI (14)74.9
MACD0.9711
MACD Signal1.0508
MACD Hist.-0.0797
BB Upper335.02 GBP
BB Middle333.50 GBP
BB Lower331.98 GBP
BB Width0.91%
ATR (14)3.174 GBP
Vol Ratio (20d)0.00x